Persistence of yellow fever vaccine RNA in urine

Vaccine

Volumn 29, Issue 18, 2011, Pages 3374-3376

  Martínez, Miguel J ^a,b   Vilella, Anna ^a,b   Pumarola, Tomás ^a,b   Roldan, Montserrat ^a   Sequera, Victor G ^a   Vera, Isabel ^a   Hayes, Edward B ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

17D; Flavivirus; Nucleic acid; Persistence; Urine; Yellow fever

Indexed keywords

VIRUS RNA; YELLOW FEVER VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; URINALYSIS; URINE; VACCINATION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; TIME FACTORS; URINE; VACCINATION; VIRAL NONSTRUCTURAL PROTEINS; YELLOW FEVER VACCINE;

EID: 79954646841     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.075     Document Type: Article

References (14)

1. Barrett A.D.T., Teuwen D.E. Yellow fever vaccine-how does it work and why do rare cases of serious adverse events take place?. Curr Opin Immunol 2009, 21(3):308-313.
2. Guy B., Guirakhoo F., Barban V., Higgs S., Monath T.P., Lang J. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue West Nile and Japanese encephalitis viruses. Vaccine 2010, 28(3):632-649.
3. Monath T., Cetron M., Teuwen D. Yellow fever vaccine. Vaccines 2008, 959-1055. Saunders Elsevier. S. Plotkin (Ed.).
4. Kuno G. Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts. Rev Med Virol 2001, 11(3):165-190.
5. Gould E.A., Buckley A., Cane P.A., Higgs S., Cammack N. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools. J Gen Virol 1989, 70(Pt 7):1889-1894.
6. Tesh R.B., Siirin M., Guzman H., Travassos da Rosa A.P.A., Wu X., Duan T., et al. Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis 2005, 192(2):287-295.
7. Siirin M.T., Duan T., Lei H., Guzman H., da Rosa A.P.A.T., Watts D.M., et al. Chronic St. Louis encephalitis virus infection in the golden hamster (Mesocricetus auratus). Am J Trop Med Hyg 2007, 76(2):299-306.
8. Pulendran B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol 2009, 9(10):741-747.
9. Domingo C., Yactayo S., Agbenu E., Demanou M., Schulz A.R., Daskalow K., et al. Detection of yellow fever 17D genome in urine. J Clin Microbiol 2011, 49(2):760-762.
10. Monath T.P., Liu J., Kanesa-Thasan N., Myers G.A., Nichols R., Deary A., et al. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci USA 2006, 103(17):6694-6699.
11. Penn R.G., Guarner J., Sejvar J.J., Hartman H., McComb R.D., Nevins D.L., et al. Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis 2006, 42(5):680-683.
12. Tonry J.H., Brown C.B., Cropp C.B., Co J.K.G., Bennett S.N., Nerurkar V.R., et al. West Nile virus detection in urine. Emerg Infect Dis 2005, 11(8):1294-1296.
13. Murray K., Walker C., Herrington E., Lewis J.A., McCormick J., Beasley D.W.C., et al. Persistent infection with West Nile virus years after initial infection. J Infect Dis 2010, 201(1):2-4.
14. Gibney K.B., Lanciotti R.S., Sejvar J.J., Nugent C.T., Linnen J.M., Delorey M.J., et al. West Nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J Infect Dis 2011, 203(3):344-347.